Wells Fargo (WFC) Discards Plan to End Personal Line of Credit
Zacks Investment Research | Aug 19, 2021 01:25AM ET
Banks are jumping on the bandwagon of streamlining operations to revive profitability amid the pandemic. Wells Fargo (NYSE:WFC) WFC , the third largest U.S. bank in terms of assets, is not an exception either.
As part of the bank’s efforts to simplify its product offerings, Wells Fargo had ceased opening new personal lines of credit in May 2020. In July 2021, it informed its customers that it would close all current personal lines of credit (PLOCs) for amounts between $3,000 and $100,000. It had also cautioned the customers about its decision’s impact on their credit scores.
The bank received complaints from customers, primarily because reducing a customer’s financing can mar their credit score and the bank’s restructuring moves should not come at the expense of customers’ credit scores.
Hence, after this move was criticized by existing customers, Wells Fargo has now reversed its decision to end those PLOCs. According to notifications viewed by Bloomberg, consumers who haven’t used their accounts since October 2020 will also be given the option of keeping them open.
As per the article by Bloomberg, the bank is allowing inactive PLOC customers until the end of November 2021 to either use their accounts or inform the bank about keeping them open or not. However, it will not grant PLOCs to new customers.
The unsecured PLOCs were granted to borrowers with robust track records. However, now people have numerous options, such as credit cards with emulous rewards programs, or online lending platforms, personal and home equity loans and financing for larger purchases, on which dealers or retailers provide 0% interest rates. Despite this, PLOCs remain a favored source of funding for long-time consumers of the bank.
Under the leadership of the bank’s CEO, Charlie Scharf, Wells Fargo has been retreating from businesses deemed needless, with the goal of streamlining operations and enhancing profitability after years of scandals.
Shares of this Zacks Rank #3 (Hold) company have gained 28.8% over the past six months compared with the industry 's growth of 11.6%.
Image Source: Zacks Investment Researchh3 Conclusion/h3
Since the breakout of the bogus account openings scandal in late 2016, Wells Fargo has been involved in a number of probes and lawsuits, which have kept its expense level elevated and eroded earnings. Moreover, the bank’s assets position has been capped at $1.95 billion by the Federal Reserve.
Nonetheless, the financial services firm has diligently undertaken several remedial measures and initiatives to remain afloat, which include divestiture/closure of non-core operations.
Markedly, Wells Fargo has been making moves to concentrate on businesses core to its consumer and corporate client base, while divesting stake in the less attractive ones. In fact, this March, the company signed a definitive agreement to sell its Corporate Trust Services business to Australia-based Computershare Limited for $750 million. The transaction, likely to close in the second half of 2021, is subject to customary closing conditions.
Also, in February, it signed a deal to divest its asset management business to private equity firms GTCR LLC and Reverence Capital Partners, L.P. The transaction has been valued at $2.1 billion and is expected to close in the second half of 2021.
h3 Stocks to Consider/h3Better-ranked stocks in the financial space include The Bancorp (NASDAQ:TBBK), Inc. the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here .
The Bancorp’s earnings estimate moved 1.1% north for the ongoing year, in the past month. Also, its share price has appreciated 17.7%, over the last six months.
Bank First’s current-year earnings estimate has been revised 4.1% upward, over the last 30 days. Further, its shares have gained 0.1%, in the last six months.
Citizens Financial (NYSE:CFG) witnessed marginal upward earnings estimate revision for the ongoing year, in the past 30 days. Moreover, its shares have rallied 11.8% in six months’ time.
Get The News You Want
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.